The utility of echocardiographic evaluation of donor hearts upon the organ procurement for heart transplantation  by Hashimoto, Shuji et al.
Journal of Cardiology (2011) 57, 215—222
avai lab le at www.sc iencedi rec t .com
journa l homepage: www.e lsev ier .com/ locate / j j cc
Original article
The utility of echocardiographic evaluation of donor
hearts upon the organ procurement for heart
transplantation
Shuji Hashimoto (MT)a, Tomoko S. Kato (MD, PhD)b,c,∗,
Kazuo Komamura (MD, PhD, FJCC)b,c, Akihisa Hanatani (MD, PhD)d,
Kazuo Niwaya (MD, PhD)e, Toshihiro Funatsu (MD, PhD) f,
Junjiro Kobayashi (MD, PhD)g, Yoshiyuki Sumita (MT)a, Norio Tanaka (MT)a,
Kazuhiko Hashimura (MD)b,h, Masanori Asakura (MD, PhD)b,
Hideaki Kanzaki (MD, FJCC)b, Masafumi Kitakaze (MD, PhD, FJCC)b
a Department of Clinical Physiology, National Cerebral and Cardiovascular Center, Osaka, Japan
b Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan
c Department of Organ Transplantation, National Cerebral and Cardiovascular Center, Osaka, Japan
d Department of Cardiology, Osaka City University School of Medicine, Osaka, Japan
e Department of Surgery and Cardiology, Garatia Hospital, Osaka, Japan
f Department of Cardiovascular Surgery, Kansai Rosai Hospital, Osaka, Japan
g Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan
h Department of Medicine, Yao Municipal Hospital, Osaka, Japan
Received 29 July 2010; received in revised form 30 October 2010; accepted 9 November 2010
Available online 14 January 2011
KEYWORDS
Heart
transplantation;
Summary
Background: Evaluating donor heart as accurately as possible upon the organ procurement would
help lead careful post-transplant heart management. Our institution (National Cerebral and Car-Echocardiography; diovascular Center, Osaka, Japan) has sent a transplant cardiologist upon the organ procurement
t ever since our ﬁrst case of heart transplantation.for evaluating a donor hearOrgan procurement;
Outcome Methods: Thirteen consecutive bedside echocardiograms obtained from donors upon the organ
procurement and post-transplant echocardiograms obtained from their recipients were retro-
spectively reviewed. The impact of donor echocardiograms on their recipients’ post-transplant
time course was analyzed and both the donor echocardiographic parameters and their recipi-
ents’ parameters within 1 week after the heart transplant were compared.
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Results: Both the left ventricular end-diastolic diameter and the ventricular wall thickness
of donors correlated well with those parameters of their corresponding recipients (r2 = 0.740,
p < 0.0001, r2 = 0.704, p < 0.0001, respectively). The information on coronary ﬂow of the donor
heart with risk factors for ischemic heart disease was useful for judging the availability for heart
transplantation. The information on the pre-existing localized wall motion abnormality of donor
hearts was useful for ruling out a possibility of rejection and other causes of wall motion abnor-
mality after transplantation. The mean time required for bedside echocardiography for the donor
heart was only 3.7min. None of the recipients either developed primary graft failure or required
treatment for cellular rejection.
Conclusions: Detailed observation of donor hearts by bedside echocardiograms upon the organ
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Bedside echocardiography on a potential donor heart wasprocurement is of clinical be
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eart transplant (HTx) provides considerable survival ben-
ﬁts for patients with end-stage heart failure; however,
Tx is available for only a small fraction of these patients
ue to donor shortages all over the world [1,2]. In par-
icular, the number of HTx surgeries completed in Japan
as been remarkably small compared to that in other
ountries [3], because the domestic legal issues in Japan
everely limit the number of organ donations. The mean
aiting period of Japanese HTx candidates was often more
han 2 years and occasionally reached 4 years even after
he introduction of ventricular assist device surgery [4].
inally, the Organ Transplant Law in Japan was revised
n July 2009. In light of the enforcement of the Revised
rgan Transplant Law in Japan, the number of HTx surg-
ries in Japan is expected to greatly increase in the near
uture.
Up to the present, transplant physicians in Japan have
ade a considerable effort to increase the number of trans-
lants in Japan under the circumstances of extremely severe
onor shortage. It has been reported that adequate and opti-
al use of all possible donor organs would be mandatory
o increase graft availability [5,6]. Fukushima et al. have
reviously described the distinctive strategies for the donor
valuation and the management system to maximize car-
iac and lung donors in Japan [6]. Since November 2002, a
ransplantation medical consultant doctor, who is an expert
ransplant cardiothoracic surgeon, has been sent to the pro-
urement hospital by the Japan Organ Transplant Network
or the purpose of assessment of donor organ function, man-
gement of donor hemodynamics, and prevention of any
ossible infections before the arrival of the harvest teams
6]. Transplantation medical consultant doctors sent by
he Japan Organ Transplant Network also perform echocar-
iography and abdominal ultrasound on potential donors
n order to eliminate inadequate organs to be donated.
ased on the information from the transplantation med-
cal consultant doctors, each potential recipient center
ould decide whether or not its organ procurement team
hould be sent to the donor hospital. In addition, each
ransplant center in Japan has also made an effort to dis-
eminate a concept of transplantation to the entire nation
nd energetically appeal to the community by accomplish-
ng good outcomes of HTx [7]. Evaluating donor heart as
ccurately as possible upon the organ procurement would
ring essential information to their recipient team, lead-
p
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ng to delicate and careful post-transplant management
f the heart. As of March 2010, 69 HTx surgeries have
een performed in Japan, and among those 27 transplants
39.1% of all HTx cases performed in Japan) were performed
t our institution, the National Cerebral and Cardiovas-
ular Center (NCVC), Osaka, Japan. Our institution has
ent both transplant cardiologist and echocardiographic
pecialist upon the organ procurement accompanied by a
urgical team for evaluating a donor heart ever since our
rst case of HTx surgery [8]. In the present study, we
eviewed the bedside echocardiograms at organ procure-
ent obtained from 13 consecutive transplant recipients
ho were transplanted since 2005. This is the ﬁrst detailed
eport describing the echocardiograms of donor hearts and
heir impact on both transplant surgery and post-transplant
anagement.
ethods
atients and study design
he ﬁrst HTx surgery at NCVC was performed in May 1999 [8].
ince then, 27 patients (39.1% of all HTx cases performed
n Japan) have undergone HTx surgery as of March 2010 at
CVC [7]. We have sent both transplant cardiologist and
chocardiographic specialist upon the organ procurement
ccompanied by a surgical team on all occasions of trans-
lant surgery for graft evaluation and collecting information
n the heart. Among those, we retrospectively reviewed
3 consecutive bedside echocardiograms on donor hearts
t the time of organ procurement and the echocardiograms
n their recipients recorded after HTx, whose HTx surgery
as been performed since October 2005. We excluded the
ecipients who had HTx before October 2005 because we
tarted to store the echocardiographic images of their donor
earts digitally for review and off-line analysis after HTx
ince October 2005.
edside echocardiography on potential donorerformed using either the equipment at the donor hos-
ital or our own Vivid I system (GE-Vingmed Ultrasound
S, Horten, Norway). We brought our portable echocar-
iographic machine (Vivid I system) to the donor hospital
t
a
S
D
e
e
m
a
s
c
l
a
r
u
R
T
t
w
r
d
t
d
i
t
p
o
G
m
i
h
o
p
p
a
l
7
w
t
w
f
d
p
h
w
m
t
g
a
h
eEchocardiography on donor heart for transplant evaluation
for evaluating donor heart upon the organ procurement.
Standard echocardiographic parameters, the area and distri-
bution of ventricular wall motion abnormality, the presence
or absence of atrial/ventricular septal defect, the presence
or absence of valvular disease including valvular calciﬁ-
cation were evaluated. In addition, coronary artery ﬂow
velocity of the left anterior descending artery was measured
if the donor had any risk factors for ischemic heart disease.
Risk factors for ischemic heart disease were deﬁned as a
current existence or past history of hyperlipidemia, hyper-
tension, diabetes, or smoking, and older than 50 years of
age. The standard echocardiographic examination included
measurements of thickness of the ventricular septum and
left ventricular (LV) posterior wall, and end-systolic and
end-diastolic LV diameters from M-mode or 2-D imaging.
LV ejection fraction was calculated by biplane Simpson’s
method from apical 4- and 2-chamber views [9]. Mitral
inﬂow was obtained by pulsed-wave Doppler echocardiog-
raphy with the sample volume between mitral leaﬂet tips
during diastole, and peak early (E) and late (A) transmi-
tral ﬁlling velocities, their ratio (E/A) and deceleration
time of E were measured. Early diastolic annular veloc-
ity (E′) was obtained by placing a tissue Doppler sampling
volume at the septal and lateral mitral annulus in the api-
cal 4 chamber view, and the E/E′ ratio was calculated in
a subset of 7 donors, whose bedside echocardiograms at
the time of procurement were recorded using a machine
equipped for tissue Doppler imaging. All donors were brain
dead and on mechanical ventilation and with minimum dose
of catecholamine and vasopressin for stabilization of hemo-
dynamics.
Echocardiography on recipients’ heart after
transplant surgery
We performed scheduled echocardiography on HTx recipi-
ents at least more than once a week until 1 month of the
heart transplantation, or when rejection/any hemodymamic
changes were suspected. Post-HTx echocardiographic eval-
uation was performed using Vivid 7 (GE-Vingmed Ultrasound
AS) with a M3S transducer. We used post-transplant echocar-
diographic measurements recorded within a week from their
transplant surgery for comparison with the measurements
obtained from their donors at the time of procurements. At
the time of image acquisition, all recipients were in a sta-
ble hemodynamic condition with minimum dose or none of
inotropic support.
Assessment of the impact of donor’s bedside
echocardiography on transplantation
The clinical time course of each patient during early
postoperative period regarding development of rejection
or graft dysfunction was retrospectively reviewed. The
diagnosis of cellular acute rejection was based on the
conventional International Society for Heart and Lung
Transplantation (ISHLT) criteria [10]. Antibody-mediated
rejection was deﬁned in this study as positive staining for
C4d at the capillary in the biopsy specimen, with or with-
out hemodynamic deterioration [11,12]. The correlation
between echocardiographic measurements obtained from
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he donor hearts and those from their recipients was evalu-
ted.
tatistical analysis
ata are presented as means± SD. The correlation between
chocardiographic measurements obtained from bedside
chocardiography at the time of organ procurement and
easurements obtained from their recipients measured
fter HTx surgery was determined with the use of Pear-
on’s correlation coefﬁcient and the interclass correlation
oefﬁcient (ICC). The correlation between degree of valvu-
ar disease or wall motion abnormality obtained from donor
nd that of recipient was analyzed by Spearman’s rank cor-
elation coefﬁcient. All statistical analyses were performed
sing JMP6.0 software (SAS Institute, Cary, NC, USA).
esults
able 1 summarizes the demographic and clinical data from
he studied patients. The primary disease that needs HTx
as non-ischemic cardiomyopathy for all the patients. The
ecipients’ age ranged from 19.5 to 51.0 years, whereas the
onors’ age ranged from 21.3 to 59.2 years. The ischemic
ime of donor hearts ranged from 166 to 235min. Seven
onors (53.8%) had risk factors for ischemic heart disease
ncluding 4 smokers.
None of the recipients developed primary graft dysfunc-
ion or hemodynamic compromise in the early postoperative
eriod. None of the patients developed cellular rejection
f ISHLT grade 3a or severer rejections (revised grading of
rade 2R [13]), although two patients developed antibody-
ediated rejection requiring either steroid pulse therapy,
ntravenous immunoglobulin, or plasmapheresis. Two donor
earts were found to have arterial septal defect at the time
f donor heart procurement, which was ﬁxed during trans-
lant surgery.
Table 2 summarizes the comparison of echocardiographic
arameters between the results obtained from donors
nd their recipients. The LV ejection fraction was excel-
ently preserved in all recipients (range 60.7—79.6%, mean
0.2± 6.0%). The LV diameters obtained from the donors
ere well correlated with the LV diameters obtained from
heir recipients (Fig. 1a). The LV mass index of the donor
as also well correlated with the LV diameters obtained
rom their recipients. Based on the information on the
onor heart size expressed as LV diameter, the trans-
lant team made a medical decision as to whether the
eart was of proper size for the candidate recipient who
ould be receiving the heart. Especially when the mis-
atch of donor—recipients body mass index was greater
han 20% [14], we focused attention on the echocardio-
raphic results of donor heart size for considering the
ppropriateness of the recipient selection. Indeed, we
ave performed the transplant surgery in 2 male recipi-
nts although their donors were female with the height of
ore than 20 cm shorter and body mass index of about 25%
maller than the recipients, according to the donor echocar-
iographic evaluation indicating sufﬁcient heart size. For
ecipients who received a small heart based on the bed-
ide donor echocardiographic evaluation at the time of
218 S. Hashimoto et al.
Table 1 Patients’ characteristics and outcome.
Clinical characteristics of patients before heart transplantation
Age at HTx (years) 40.4± 9.1
Male (%) 8 (61.5%)
Mean BMI (kg/m2) 19.8± 2.0
Mean BSA (m2) 1.54± 0.1
LVAD implantation (%) 12 (92.3%)
Reason for HTx
Idiopathic DCM 10 (78.2%)
Cardiac sarcoidosis 2 (13.0%)
ARVC 1(0%)
Donor information
Donor age (years) 40.4± 10.8
Mean BSA (m2) 1.58± 0.2
Donor heart ischemic time (min) 210.8± 19.4
Risk factor for ischemic heart disease (%) 7 (53.8%)
Donor and recipient sex (donor→ recipient)
Male→male 6 (46.1%)
Male→ female 2 (15.3%)
Female→male 2 (15.3%)
Female→ female 3 (23.1%)
Rejection within 2 weeks and coronary artery disease at the ﬁrst angiogram
Number of patients with rejection of≥ ISHLT grade 2 0(0%)
Number of patients with antibody mediated rejection 2 (15.3%)
Angiographically apparent coronary stenosis 3 (23.1%)
MIT of 0.5mm on IVUS at the ﬁrst study 4 (30.7%)
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ARVC, arrhythmogenic right ventricular cardiomyopathy; ISHLT, In
intimal thickness; IVUS, intravascular ultrasound.
rgan procurement including the above-described 2 male
ecipients, we had paid considerable attention to hemo-
ynamics after HTx surgery such as gradual diminution
f inotropic support and/or relatively longer duration of
ressure monitoring with Swan-Ganz catheter. The infor-
ation about ventricular wall thickness of the donor hearts
orrelated well with the ventricular thickness of their recip-
ents measured after transplant as well (Table 2, Fig. 1b).
ccording to the donor heart information about ventricular
ypertrophy, which could be safely used in the heart trans-
lantation to expand the donor pool [15], we administered
ardioprotective agents, such as angiotensin-converting
nzyme inhibitors, angiotensin receptor blockers, and cal-
ium antagonists as soon as possible after HTx surgery for
ecipients who were preliminarily known to have received
ypertrophic hearts. We experienced 2 patients with anti-
ody mediated rejection in the early postoperative period,
ho showed a relatively increased LV wall thickness and LV
ass at the time of rejection. We could suspect a possibil-
ty of antibody mediated rejection even without evidence
f cellular rejection according to the information on their
onor LV wall thickness. In these cases, donor bedside
chocardiography was very useful to consider the timing
f rejection treatment and/or further rejection surveil-
ance.The degree of valvular regurgitation of the donor heart
id not always correspond with the degree of that seen in
heir recipients. In addition, peak early (E) and late (A)
ransmitral ﬁlling velocities and their ratio (E/A) (Fig. 1c),
nd deceleration time of E obtained from donors and their
o
r
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FVAD, left ventricular assist device; DCM, dilated cardiomyopathy;
tional Society for Heart and Lung Transplantation; MIT, maximum
ecipients were not corresponding with each other, either.
either the E′ nor the E/E′ of the donor hearts were in agree-
ent with the parameters measured in their recipients after
Tx surgery.
The left anterior descending coronary artery ﬂow was
ecorded in 7 donors with risk factors for ischemic heart
isease, but they did not show a sign of signiﬁcant organic
oronary obstruction [16,17]. The mean diastolic-to-systolic
oronary ﬂow velocity ratio was greater than 1.4 for all 7
onor hearts with the risk factors [16], thus we decided to
erform proceeding HTx surgery with the use of the donor
earts based on this information. For the patients with risk
actors for ischemic heart disease, the ﬁrst angiogram to
valuate coronary artery disease of the donor was performed
weeks from the HTx surgery, ahead of our routine schedule
f 3 months after the transplants. None of the patients who
eceived a donor heart with ischemic risk factors showed
igniﬁcant coronary artery stenosis greater than 75% at
he time of ﬁrst angiography. However, 2 patients whose
onor hearts showed mean diastolic-to-systolic coronary
ow velocity ratio of 1.4 were revealed to have about 50%
tenosis on left anterior descending coronary artery at their
rst angiogram. They were then treated with intensive med-
cation to prevent progression of transplant coronary artery
isease including administration of a maximum dose of statin
r/and early conversion to everolimus therapy [18—20]. Rep-
esentative recording of the coronary ﬂow obtained from
donor heart, whose recipient showed coronary irregular-
ty at the ﬁrst angiogram after the HTx surgery is shown in
ig. 2.
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Table 2 Echocardiographic parameters obtained from the donors and their recipients.
Parameter Donor echocardiogram (n = 13) Recipient echocardiogram (n = 13) ICC
Vital signs at the time of echocardiography
Day of echocardiography performed 3.4± 1.2 h before harvest surgery 3.7± 1.6 days after HTx surgery —
Systolic blood pressure (mmHg) 117.5± 13.5 109.6± 7.8 —
Diastolic blood pressure (mmHg) 78.8± 11.9 72.6± 10.4 —
Heart rate (bpm) 92.0± 2.5 91.0± 5.6 —
Conventional echocardiographic parameters
LVDd (mm)* 39.1± 3.5 40.3± 3.8 0.86
LVDs (mm) 24.8± 2.9 22.6± 3.4 0.79
IVST (mm)* 10.0± 1.5 12.0± 1.6 0.94
PWT (mm)* 11.1± 1.9 11.1± 1.8 0.95
LVMI (g/m2)* 113.0± 21.5 110.6± 29.7 0.87
LVEF (%) 62.3± 6.4 70.2± 6.0 0.25
TMF E (cm/s) 66.5± 15.4 78.8± 16.5 0.53
TMF E/A 1.7± 0.6 2.1± 0.6 0.42
TMF DcT (ms) 199.4± 30.3 161.4± 35.0 0.32
Tissue Doppler echocardiographic parameters (subgroup of 7 patients studied)
E/E′ (septal) (cm/s) 7.6± 2.7 8.1± 2.4 0.57
E/E′ (lateral) (cm/s) 12.1± 2.2 11.3± 3.1 0.20
Left anterior descending coronary artery ﬂow (subgroup of 7 patients studied)
Diastolic-to-systolic ﬂow velocity ratio * 1.6± 0.1 1.7± 0.2 0.79
Other ﬁndings (number of patients, %)
Septal defect 2 (15.3%) — (ﬁxed) —
Mitral valve calciﬁcation 0 (0%) 0 (0%) —
Aortic valve calciﬁcation 0 (0%) 0 (0%) —
Mild to moderate mitral regurgitation 2 (15.3%) 2 (15.3%) 0.46
Mild to moderate tricuspid regurgitation 2 (15.3%) 3 (23.1%) 0.49
Localized wall motion abnormality* 3 (23.1%) 4 (30.7%) 0.89
ICC, interclass correlation coefﬁcient; HTx, heart transplant; LV, left ventricular; LVDd, LV end-diastolic internal dimension; LVDs, LV
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index; LVEF, LV ejection fraction; TMF, transmitral ﬂow; DcT, dece
* p < 0.001 by correlation analysis between the values obtained
Three donor hearts showed a localized wall motion abnor-
mality at the apex. Both area and distribution of the wall
motion abnormality found in each donor heart were also
seen at the identical area and distribution in each recipient
heart. This concordance of localized wall motion abnor-
mality between donor and recipients meant that the wall
motion abnormality of the recipient in the early postoper-
ative period was not a newly developed abnormality which
was unlikely caused by rejection or primary graft dysfunc-
tion. Accordingly, transplant physicians could just observe
the changes in serial echocardiographic ﬁndings without
doing any emergent tests to rule out the cause of the wall
motion abnormality.
The time required for acquisition of images of bed-
side echocardiogram for donor heart evaluation was
3.7± 1.3min.
DiscussionIn the present study, we have demonstrated the utility
of bedside echocardiographic evaluation of donor hearts
upon organ procurement. These are (a) the size of donor
hearts measured by bedside echocardiography was in good
agreement with the heart size measured after HTx surgery
e
d
t
eseptum; PWT, thickness of the LV posterior wall; LVMI, LV mass
ion time of E.
donors and their recipients.
btained from their recipients, which seems to be useful
nformation for the judgment of proceeding with HTx espe-
ially in case of donor—recipient size mismatch; (b) the wall
hickness of donor hearts derived from bedside echocardio-
raphy was also in good agreement with the wall thickness
f their recipients measured after HTx surgery, and this
nformation helped transplant physicians to optimize post-
ransplant medical therapy for the recipients who received
ypertrophic hearts; (c) the information concerning septal
efect would be of help for surgeons to prospectively plan
he additional procedure of septal closure at the time of
Tx surgery; (d) the information on coronary ﬂow in left
nterior descending artery of the donor heart with some
isk factors for ischemic heart disease was useful for judg-
ng the availability of the heart, as well as for considering
ost-HTx medical management; (e) the information on pre-
xisting localized wall motion abnormality of donor hearts
etected by bedside echocardiography was useful to con-
ider a possibility of rejection and other causes of wall
otion abnormality; (f) the mean time required for bedside
chocardiography on donor heart was only 3.7min, and this
uration was reasonable for donor hospital and other organ
eam to accept our noninvasive evaluation of the graft.
We speculate that the discordances between the param-
ters of E, E/A, E′ and E/E′, and the degree of valvular
220 S. Hashimoto et al.
Figure 1 Correlations of the echocardiographic parameters
between the value obtained from the donor at the time of
organ procurement and the value obtained from their recipient
within a week from transplant surgery regarding left ventricular
end-diastolic diameter (LVDd) (a), ventricular septal wall thick-
ness (IVST) (b), and the ratio of peak early and late transmitral
ﬁlling velocities (TMF E/A ratio) (c). Closed circles represent
the variables obtained from the same hearts before and after
heart transplant surgery. Solid line indicates the correlation of
variables obtained from donors and their recipients.
Figure 2 Representative recording of Doppler ﬂow imaging
of distal left anterior descending coronary artery (a) obtained
from a donor heart with risk factors for ischemic heart disease,
and the ﬁrst angiogram of the recipient who received the heart
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phich was performed in the month after transplant surgery
b). The arrow indicates about 50% narrowing of left anterior
escending coronary artery.
egurgitation between the donors and their recipients were
ttributable to the difference of volume status between
re- and post-transplant. These Doppler-derived parameters
ere subjected to the preload status [21]; therefore, abnor-
ality of these parameters in donor hearts would not be a
actor inﬂuencing the decision of the heart availability.
One of the main focuses of bedside echocardiography
n potential donor hearts is to determine the appropri-
teness of the use of the hearts for donation. In Japan,
transplantation medical consultant doctor who is sent
y the Japan Organ Transplant Network preliminarily per-
orms echocardiography on a potential donor to eliminate
nadequate hearts to be donated, before the organ pro-
urement team is sent to the donor hospital. Thus, we,
s an organ procurement team, who have known which
atient is going to receive the heart, perform more detailed
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bedside echocardiography on the donor in the light of our
potential recipient’s detailed information upon the organ
procurement. We actually decided not to harvest the donor
heart only once during this study period according to our
own bedside echocardiography, although the information
from a transplantation medical consultant doctor about
the heart was adequately enough to use the organ. The
donor heart was relatively small for our potential recipi-
ent and showed decreased coronary ﬂow and localized right
heart wall motion abnormality upon the organ procurement;
on the other hand our potential recipient had moderately
high pulmonary vascular resistance and needed to receive a
donor heart with good right ventricular function. That was
why we decided not to harvest the donor heart. We imme-
diately reported our decision and the results of our bedside
echocardiography to the Organ Transplant Network.
Although this is a single-center retrospective analysis of
small numbers of HTx donors and their recipients’ echocar-
diograms, our institution is the biggest HTx center in Japan
where so far 40% cases of HTx surgeries were performed.
Thus, our endeavor to bring sufﬁcient information on the
donor hearts upon organ procurement to the transplant sur-
geons and physicians who were in charge of the recipients’
post-transplant care for the purpose of successful outcome
of HTx would bear mentioning. There had been a consider-
able effort by Fukusima et al. for maximizing the heart and
lung transplant opportunities in Japan, such as the system
of a special transplantation consultant doctor being sent to
the donor hospital for evaluating the donor organs and stabi-
lizing donor hemodynamics before the arrival of the harvest
teams [6]. In addition to such efforts of maximizing the pos-
sible donor pool, each transplant center in Japan also has a
responsibility of evaluating the donor heart. A good outcome
after HTx surgery would be a key factor for undertaking
transplantation in Japan. The survival rate of Japanese HTx
recipients after HTx surgery has been excellent even com-
pared to that in the International Heart Transplant Registry
[7]. The excellent survival of Japanese recipients seems to
be based on their excellent compliance with drugs and rou-
tine clinical visits due to full coverage of healthcare services
provided by the National Health Insurance System; addi-
tionally, we believe that it was also due to the outstanding
Japanese transplant physicians’ endeavor. In order to gather
as much information as possible, also in order to limit the
evaluation time to be as short as possible, our institution
sent our cardiac transplant cardiologist and echocardiogra-
pher to the donor hospital, who were experienced in HTx.
The limitation of this study was that the echocardio-
graphic parameters obtained from the same hearts before
and after HTx were recorded by different echocardiographic
machines. Another limitation of this study was that we did
not consider the dose of inotropic support before and after
HTx when we compared the echocardiographic parameters.
In addition, we could not report the detailed information on
donors’ demographics because of privacy protection in rela-
tion to personal data and because of the extremely small
number of transplants in Japan. We did not have any pedi-
atric cases in this observation, because the Previous Organ
Transplant Law in Japan prohibited brain-death tests under
15 years old. That may be a reason we could show statis-
tical correlations between donors and their recipients in
the value of LV size and LV mass. In a decade of pediatric221
ransplants that will be performed under the Revised Organ
ransplant Law, then body-size mismatch would be a more
mportant determinant in organ procurement. Thus, evalu-
tion of LV size and LV mass by echocardiograms would be
ore necessary.
Despite several limitations, we still believe that we have
chieved an excellent result of HTx recipients to be proud of
7] due to our signiﬁcant effort of evaluating donor heart as
arefully as possible and our strategy is worthwhile report-
ng. The number of HTx surgeries is expected to increase
n the near future in Japan under the Revised Organ Trans-
lant Law. Therefore, we hope that all transplant physicians
n Japan ﬁnd our detailed observation of donor hearts by
chocardiograms reported here is of clinical beneﬁt.
In conclusion, bedside echocardiogram upon organ pro-
urement by transplant center’s own staff is a unique system
round the world, but we believe that it played a great role
n improving the outcome after HTx.
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